Dr. Mathilde Krim, amfAR’s Founding Chairman, dies at 91. In remembrance, The New York Times calls her “America’s foremost warrior in the battle against superstitions, fears and prejudices that have stigmatized many people with AIDS.”
The NIH launches a large international study to compare the safety and efficacy of antiretroviral treatment regimens for pregnant women living with HIV and their infants.
A global analysis, reviewing studies involving nearly 800,000 people from 153 countries, finds that people living with HIV are twice as likely as their HIV-negative counterparts to suffer from heart disease.
The WHO certifies that Malaysia has eliminated mother-to-child transmission of HIV.
A study reports that targeted, high-coverage roll-out of PrEP is associated with a 25% reduction in new HIV diagnoses in one year. It is the first study to test PrEP’s population-level effectiveness.
amfAR-funded researchers at the European IciStem consortium report a “profound” reduction in the HIV reservoirs of five patients who have received stem cell transplants.
